Home › NDC Lookup › RxCUI directory › RxCUI 1855389

Levalbuterol 2.5 MG/ML Inhalation Solution — RxCUI 1855389

RxNorm drug concept · Semantic clinical drug
RxCUI 1855389 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1855389
Official nameLevalbuterol 2.5 MG/ML Inhalation Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevalbuterol HCl 1.25 MG per 0.5 ML Inhalation Solution; levalbuterol HCl concentrate 1.25 MG in 0.5 ML Inhalation Solution
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)600 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levalbuterol Oral Inhalation: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Levalbuterol is a rescue bronchodilator — it's used to quickly open up your airways when they tighten up, like during an asthma attack or a flare of bronchospasm. Xopenex inhalatio...
  • The concentrate form has to be diluted with sterile normal saline before you put it in the nebulizer — never use it straight from the vial without diluting first. You then breathe...
  • How do I use the nebulizer solution correctly?
  • The most common ones are shakiness (tremor), nervousness, a faster heartbeat, headache, and dizziness — especially when you first start using it. These are usually mild and tend to...
📖 Read our full Levalbuterol Oral Inhalation guide →

🕸️ Concept Web — How Levalbuterol 2.5 MG/ML Inhalation Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Levalbuterol 2.5 MG/ML Inhalation Solution RxCUI 1855389

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Levalbuterol 237159
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xopenex 261702
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Levalbuterol Inhalation Solution 2108209
    • Levalbuterol Inhalant Product 1163444
    • Levalbuterol Inhalation Solution [Xopenex] 2108213
    • Xopenex Inhalant Product 1186445
    • Inhalation Solution 346161
    • Inhalant Product 1151123
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Levalbuterol 2.5 MG/ML 1855388
    • Levalbuterol 2.5 MG/ML Inhalation Solution [Xopenex] 1855391
    • Levalbuterol 2.5 MG/ML [Xopenex] 1855390

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Levalbuterol 2.5 MG/ML SCDC · 1855388
  • Levalbuterol Inhalation Solution SCDF · 2108209
  • Levalbuterol Inhalant Product SCDG · 1163444

Brand-Name Concepts

  • Levalbuterol 2.5 MG/ML Inhalation Solution [Xopenex] SBD · 1855391
  • Levalbuterol 2.5 MG/ML [Xopenex] SBDC · 1855390
  • Levalbuterol Inhalation Solution [Xopenex] SBDF · 2108213
  • Xopenex Inhalant Product SBDG · 1186445
  • Xopenex BN · 261702

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1855389 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00378-6993-93 30 POUCH in 1 CARTON (0378-6993-93) / 1 VIAL in 1 POUCH (03... Levalbuterol Mylan Pharmaceuticals Inc. 2009-08-28
65862-0942-03 30 POUCH in 1 CARTON (65862-942-03) / 1 VIAL, SINGLE-DOSE i... LEVALBUTEROL Aurobindo Pharma Limited 2017-01-31
Observed labelers: Aurobindo Pharma Limited (1) · Mylan Pharmaceuticals Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J7612 Levalbuterol non-comp con 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.